The Autonomous AI Scientist of 2030 Needs Inferential Arbitrage

Abstract

Across AI-driven science, generative capacity has outpaced investigative judgment. It is now possible to produce millions of plausible candidates in hours, but not yet to decide which merit expensive validation. This asymmetry defines the central bottleneck of scientific discovery for the next decade. This blue sky paper casts scientific investigation as an information market. A strategically intelligent agent must exploit cost-information asymmetries across fidelity levels, purchasing cheap inferences to decide whether expensive ones are worth acquiring. The paper formalizes this principle as Inferential Arbitrage: a multi-fidelity Markov Decision Process in which agents maximize inferential return on investment. The formulation is pluralistic by design, admitting reinforcement learning, evolutionary algorithms, and multi-armed bandits. The framework is developed in protein design, where the vendor hierarchy from sequence embeddings to wet-lab assays spans several orders of magnitude, but the same structure recurs in materials science and autonomous chemistry. Three grand challenges (cross-modal calibration, asynchronous decision logic, interpretable strategy) anchor a 2030 benchmark: an agent that discovers a functional protein at 1% of the compute and 10% of the lab cost of human-designed pipelines. The ultimate measure of an autonomous AI scientist is not what it can compute, but what it chooses not to.